Form 8-K - Current report:
SEC Accession No. 0001398733-26-000033
Filing Date
2026-06-10
Accepted
2026-06-10 16:02:32
Documents
11
Period of Report
2026-06-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20260610.htm   iXBRL 8-K 37218
  Complete submission text file 0001398733-26-000033.txt   151480

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20260610.xsd EX-101.SCH 1776
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20260610_lab.xml EX-101.LAB 21629
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20260610_pre.xml EX-101.PRE 12504
14 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20260610_htm.xml XML 2719
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 261079577
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)